Desigualdade no acesso a medicamentos para doenças crônicas em mulheres brasileiras

Abstract

Desigualdade no acesso a medicamentos para doenças crônicas em mulheres brasileiras Inequality in Brazilian women's access to medicines for chronic diseases Inequidad en el acceso a medicamentos para enfermedades crónicas en mujeres brasileñas

Acesso da população brasileira adulta a medicamentos prescritos

“…The adjusted analysis for the evaluation of the factors associated with the access to medication reinforces the existing inequalities in access, verified in other studies 4,10,13,16,24 , given the observation of significant differences in the prevalence rates in relation to sociodemographic conditions.…”

“…The high prevalence of access to prescribed medications corroborates the findings in different studies in Brazil 3,4,6 . However, the verified prevalence was lower to that observed by other authors, who assessed specific groups (elderly and women) based on the data from the last health supplement in the National Household Sample Survey (PNAD), in 2008 (86%) 3 and the National Study of Women and Children Demography and Health, from 2006 (87.4%) 4 . However, it is important to point out that the attributed diferences may be related to the fact that these studies only investigated the access to continuous-use medications, which present higher access to the population 6 .…”

“…Besides, only 15.3% had full access to medications prescribed by the Unified Health System (SUS). Many studies have shown the low acquisition of medications by SUS 3,9,10,16 and high proportion of access by purchase 4 , including continuous-use medications 3 , also those for chronic conditions, such as hypertension and diabetes 6 , which are part of the essential medications provided by SUS. According to the health satellite-account, Brazilian families have financed 90% of the final intake of medications 21 , corroborating the need for the direct expenditure to access the drugs.…”

“…The dependente variable was the access to medication prescribed by health professionals, classified according to the response categories: total access (all), partial (some) and null (none), and assessed according to the proposition of other studies 3, 4,6,18 , by the following question: Could the "(person's name") obtain the prescribed medication? ".…”

“…The access to medications is considered by the United Nations as one of the indicators to measure the advances in the access to the right to health 1 . However, data from the World Health Organization show that only two thirds of the world's population have regular access to these items 1 , and 15% of people living in developed countries consume more than 90% of the global production of pharmaceutical products, which shows that the access to medication is unequal, coexisting with major social inequities [2][3][4] . The lack of access to medications may lead to the aggravation of the diseases, and, consequently, people go back to health services, besides generating costs to secondary and tertiary care 5 .…”